Profile: Ajanta Pharma Ltd (AJPH.BO)

AJPH.BO on Bombay Stock Exchange

2,395.60INR
27 Jan 2015
Change (% chg)

Rs-10.75 (-0.45%)
Prev Close
Rs2,406.35
Open
Rs2,405.00
Day's High
Rs2,466.55
Day's Low
Rs2,379.00
Volume
6,795
Avg. Vol
9,895
52-wk High
Rs2,748.45
52-wk Low
Rs892.30

Search Stocks
Ajanta Pharma Limited is a pharmaceutical company engaged in development, research, manufacture and marketing of dosages in domestic and international markets. Ajanta operates with five manufacturing facilities, four in India and one in Mauritius that produce pharmaceutical products. It is engaged in commercializing generic products and combination products in the therapeutic areas of anti-malarial, cardiovascular, dermatology, male erectile dysfunction, musculoskeletal and ophthalmology. Its manufacturing capabilities include a range of dosage forms of allopathic drugs, including tablets, capsules, ointments, injections and dry powder. Its key products include the brand called Kamagra, for the treatment of Male Erectile Dysfunction (MED) and Artefan, for the treatment of malaria. The Companies subsidiaries include Ajanta Pharma (Mauritius) Limited, Ajanta Pharma USA Inc., and Ajanta Pharma Philippines Inc.

Company Address

Ajanta Pharma Ltd

Gnanananda Place, Kalapet
MUMBAI     400067
P: +9122.66061000
F: +9122.66061200

Company Web Links

Search Stocks